Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Rehabilitation Through Individualized Support and Exercise (RISE)

30 de septiembre de 2026 actualizado por: Universitaire Ziekenhuizen KU Leuven

Feasibility and Compliance of a Tailored Physiotherapy Program for Early Mobilization After Oral Cancer Surgery

Oral cancer, the most prevalent form of head and neck malignancy, represents a major global health burden, with over 370,000 new cases annually according to the World Health Organization. Surgical resection with free flap reconstruction remains the gold standard for curative treatment, yet it often entails significant functional and physical impairment. The surgical procedure often involves tumor resection and reconstruction. Postoperative complications such as dysphagia, reduced masticatory function, and prolonged immobility frequently contribute to fatigue, loss of muscle mass, and delayed recovery, ultimately impacting quality of life and overall prognosis.

Loss of skeletal muscle mass, commonly observed in this patient population, is strongly associated with impaired physical performance, reduced treatment tolerance, and increased postoperative morbidity. Recent evidence underscores that early mobilization and structured physiotherapeutic interventions can mitigate these effects, enhance functional recovery, and reduce length of hospital stay across various surgical populations. In head and neck cancer specifically, early mobilization has been associated with shorter hospitalization and fewer complications, yet practical, standardized physiotherapy protocols remain scarce and poorly defined.

Despite inclusion of early mobilization principles in Enhanced Recovery After Surgery (ERAS) pathways, current head and neck cancer guidelines lack specific recommendations regarding the timing, intensity, and content of postoperative physical activity. Furthermore, evidence on patient compliance and feasibility of such interventions during the acute hospitalization phase is limited.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Estimado)

39

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

      • Leuven, Bélgica, 3000
        • UZ Leuven
        • Contacto:
        • Sub-Investigador:
          • Jeroen Van Dessel, Dr.
        • Investigador principal:
          • Robin Willaert, Prof. Dr.
        • Sub-Investigador:
          • Lina Van Lint, MSc
        • Sub-Investigador:
          • Lynn Christiaens, MSc
        • Sub-Investigador:
          • Auke Van Mierlo, Dr.
        • Sub-Investigador:
          • Karla Van de Velde, MSc

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion criteria:

  • Age ≥18 years.
  • Histologically confirmed oral cancer.
  • Planned free fibula or DCIA flap reconstruction.
  • Ability to provide written informed consent.
  • Sufficient comprehension of Dutch to complete questionnaires.

Exclusion criteria:

  • Severe psychiatric or neurocognitive impairment (e.g., dementia, Korsakoff syndrome, schizophrenia).
  • Hemodynamic instability or contraindication to mobilization.
  • Pre-existing neuromuscular disorders severely limiting mobility.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Experimental

Patients get a tailored physiotherapy program for early mobilization after oral cancer surgery

Participants allocated to the intervention group will receive a structured, multicomponent exercise programme during the perioperative period in addition to usual care. The programme includes individually tailored aerobic, resistance, flexibility and functional exercises, supervised by trained healthcare professionals and progressively adapted according to the participant's clinical condition and recovery.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Achievement of the highest exercise progression level
Periodo de tiempo: From the first postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.

The percentage of participants who achieve the highest exercise progression level of the postoperative physiotherapy programme before hospital discharge will be reported. The highest progression level is defined as Level 4. The percentage will be calculated as the number of participants achieving this level divided by the total number of participants included in the primary feasibility analysis (n=35), multiplied by 100.

From the first postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.
Patient-reported acceptability of the intervention
Periodo de tiempo: At hospital discharge, anticipated 10 days after surgery.

Patient-reported acceptability of the physiotherapy programme will be assessed using the Acceptability of Intervention Measure (AIM). The AIM consists of four items, each rated from 1 (completely disagree) to 5 (completely agree). The participant-level score will be calculated as the mean of the four item scores, ranging from 1 to 5. Higher scores indicate greater perceived acceptability.

At hospital discharge, anticipated 10 days after surgery.
Patient-reported appropriateness of the intervention
Periodo de tiempo: At hospital discharge, anticipated 10 days after surgery.

Patient-reported appropriateness of the physiotherapy programme will be assessed using the Intervention Appropriateness Measure (IAM). The IAM consists of four items, each rated from 1 (completely disagree) to 5 (completely agree). The participant-level score will be calculated as the mean of the four item scores, ranging from 1 to 5. Higher scores indicate greater perceived appropriateness.

At hospital discharge, anticipated 10 days after surgery.
Patient-reported feasibility of the intervention
Periodo de tiempo: At hospital discharge, anticipated 10 days after surgery.

Patient-reported feasibility of the physiotherapy programme will be assessed using the Feasibility of Intervention Measure (FIM). The FIM consists of four items, each rated from 1 (completely disagree) to 5 (completely agree). The participant-level score will be calculated as the mean of the four item scores, ranging from 1 to 5. Higher scores indicate greater perceived feasibility.

At hospital discharge, anticipated 10 days after surgery.
Adherence to prescribed physiotherapy sessions
Periodo de tiempo: From the first prescribed postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.

Adherence will be assessed as the percentage of prescribed postoperative physiotherapy sessions completed by each participant. This percentage will be calculated as the number of completed sessions divided by the number of prescribed and clinically eligible sessions during the postoperative hospital stay, multiplied by 100. A completed session is defined as a supervised physiotherapy session that is initiated and delivered as planned or with clinically indicated adaptations. Sessions that are initiated but terminated before completion will be classified as incomplete, with the reason for termination recorded. Sessions withheld or terminated because the participant is clinically ineligible for physiotherapy or because of safety concerns will be reported separately and excluded from the denominator. Scores range from 0% to 100%, with higher percentages indicating greater adherence.

From the first prescribed postoperative physiotherapy session until hospital discharge, anticipated from day 1 to 10 after surgery.
Therapist-rated adherence to physiotherapy
Periodo de tiempo: Immediately after each postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.

Therapist-rated in-session engagement will be assessed immediately after each postoperative physiotherapy session using the Sport Injury Rehabilitation Adherence Scale (SIRAS). The SIRAS consists of three items, each scored from 1 to 5. Item scores are summed to obtain a session-level total score ranging from 3 to 15, with higher scores indicating greater in-session engagement. The reported participant-level outcome will be the mean of the session-level total scores across all assessed sessions.

Immediately after each postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Objectively measured physical activity
Periodo de tiempo: From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).

Physical activity will be continuously assessed using the Activ8 Physical Activity Monitor G2. Activity data will be collected throughout the perioperative period to quantify daily physical activity and sedentary behaviour. Participant diaries will be used to support interpretation of activity monitor data during the preoperative and post-discharge periods.

From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).
Anxiety symptoms
Periodo de tiempo: At baseline, 8 days before surgery

Anxiety symptoms will be assessed preoperatively using the Generalized Anxiety Disorder 2-item scale (GAD-2), with a total score ranging from 0 to 6. Higher scores indicate greater anxiety symptom severity and therefore a worse outcome. Participants scoring ≥3 will additionally complete the Generalized Anxiety Disorder 7-item scale (GAD-7), with a total score ranging from 0 to 21. Higher GAD-7 scores indicate greater anxiety symptom severity and therefore a worse outcome.

At baseline, 8 days before surgery
Baseline physical activity
Periodo de tiempo: At baseline, 8 days before surgery

Baseline physical activity and sedentary behaviour will be assessed using the Simple Physical Activity Questionnaire (SIMPAQ). The SIMPAQ assesses time spent across five activity domains: time in bed, sedentary time, walking, structured exercise, and incidental physical activity. Outcomes are reported as time spent in each activity domain rather than as a total score; therefore, no overall minimum or maximum score or direction of better outcome applies.

At baseline, 8 days before surgery
Motivation for physical activity
Periodo de tiempo: At baseline, 8 days before surgery, and at the start of the intervention, anticipated 1 day after surgery.

Motivation for physical activity will be assessed using the Behavioral Regulation in Exercise Questionnaire-3 (BREQ-3). The questionnaire assesses six forms of motivation: amotivation, external regulation, introjected regulation, identified regulation, integrated regulation, and intrinsic regulation. Each subscale is scored from 0 to 4. Higher scores indicate a greater presence of the respective type of motivation. Higher identified, integrated, and intrinsic regulation scores reflect greater autonomous motivation (better outcomes), whereas higher amotivation reflects lower motivation (worse outcome). External and introjected regulation represent more controlled forms of motivation and cannot be uniformly interpreted as better or worse outcomes. No overall BREQ-3 total score is calculated.

At baseline, 8 days before surgery, and at the start of the intervention, anticipated 1 day after surgery.
Functional lower limb performance measured by the Five Times Sit-to-Stand Test
Periodo de tiempo: At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.

Functional lower limb performance will be assessed using the Five Times Sit-to-Stand Test (5xSTS). The time required to complete five consecutive sit-to-stand repetitions will be recorded in seconds. Shorter completion times indicate better functional lower limb performance. Completion times will be reported at each assessment time point.

At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.
Functional exercise capacity measured by the Six-Minute Walk Test
Periodo de tiempo: At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.

Functional exercise capacity will be assessed using the Six-Minute Walk Test (6MWT). The total distance walked during six minutes will be recorded in metres. Greater walking distances indicate better functional exercise capacity. Walking distances will be reported at each assessment time point.

At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.
Handgrip strength
Periodo de tiempo: At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.

Handgrip strength will be assessed using a Jamar Hydraulic Hand Dynamometer and recorded in kilograms. Three attempts will be performed for each hand at each assessment time point. The mean of the three attempts will be calculated separately for the right and left hand, and results will be reported separately by hand. Higher values indicate greater handgrip strength.

At baseline, 8 days before surgery, and at hospital discharge, anticipated 10 days after surgery.
Pain intensity
Periodo de tiempo: From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).

Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. Higher scores indicate greater pain intensity and therefore a worse outcome. Pain scores will be recorded three times daily from the preoperative baseline assessment until 10 days after hospital discharge.

From baseline (8 days before surgery) until the end of follow-up (10 days after discharge).
Perceived exertion during physiotherapy
Periodo de tiempo: At the end of each supervised postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.

Perceived exertion will be assessed using the Borg Rating of Perceived Exertion (RPE) scale at the end of each supervised postoperative physiotherapy session. The scale ranges from 6 (no exertion) to 20 (maximal exertion), with higher scores indicating greater perceived exertion. The reported participant-level outcome will be the mean of the session-level ratings across all assessed postoperative physiotherapy sessions.

At the end of each supervised postoperative physiotherapy session, from the first session until hospital discharge, anticipated from day 1 to 10 after surgery.
Length of hospital stay
Periodo de tiempo: From the day of surgery until hospital discharge, anticipated 10 days after surgery.

Length of hospital stay will be recorded as the number of days from surgery until hospital discharge.

From the day of surgery until hospital discharge, anticipated 10 days after surgery.
Postoperative complications
Periodo de tiempo: From surgery until the end of follow-up (12 weeks after surgery)

Postoperative complications will be recorded and classified according to the Common Terminology Criteria for Adverse Events (CTCAE), version 5.0. Adverse events are graded from 1 to 5, with higher grades indicating greater severity: Grade 1 (mild), Grade 2 (moderate), Grade 3 (severe), Grade 4 (life-threatening), and Grade 5 (death related to the adverse event). Higher grades therefore indicate a worse outcome. No overall score is calculated.

From surgery until the end of follow-up (12 weeks after surgery)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

10 de septiembre de 2026

Finalización primaria (Estimado)

1 de enero de 2029

Finalización del estudio (Estimado)

1 de enero de 2029

Fechas de registro del estudio

Enviado por primera vez

5 de agosto de 2026

Primero enviado que cumplió con los criterios de control de calidad

30 de septiembre de 2026

Publicado por primera vez (Actual)

5 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

5 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

30 de septiembre de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • S71815

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be shared due to participant confidentiality, ethical considerations, and institutional data protection policies.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .